| AMR | antimicrobial resistance |
| WHO | World Health Organization |
| MDR | multidrug-resistant |
| ESKAPE pathogens | Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. |
| CRISPR | Clustered Regularly Interspaced Short Palindromic Repeats |
| AMPs | antimicrobial peptides |
| 3D | three-dimensional |
| NPs | nanoparticles |
| MRSA | methicillin-resistant Staphylococcus aureus |
| H2O2 | hydrogen peroxide |
| 10-HDA | 10-hydroxy-2-decenoic acid |
| CaTx-II | Crotalus adamanteus toxin-II |
| MIC | minimum inhibitory concentrations |
| MBC | minimum bactericidal concentrations |
| VRE | Vancomycin-resistant Enterococci |
| MTN | mesoporous titanium nanoparticles |
| PEI | ethylene imine polymer |
| BH | berberine hydrochloride |
| BER | berberine chloride |
| GBM | glioblastoma |
| PLGA | poly lactic-co-glycolic acid |
| ALG | blending alginate |
| MC | methylcellulose |
| LAP | laponite |
| Gen | gentamicin |
| PVA | Polyvinyl alcohol |
| MVLs | multivesicular liposomes |
| VAN HL | vancomycin hydrochloride |
| SLNs | solid lipid nanoparticles |
| NRG | naringenin |
| PM | paromomycin ulphate |
| VM-FB | vancomycin base |
| MSSA | methicillin-sensitive Staphylococcus aureus |
| PTA | target attainment |
| PK | pharmacokinetic |
| PD | pharmacodynamic |
| OHA-PBA | acid-grafted oxidized hyaluronic acid |
| SpsB | signal peptidase type IB |